✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic NeurologyClinical EvidenceEpilepsyMultiple SclerosisResearch Gaps Why This MattersThis systematic mapping of 47 neurological trials...
Research, Development, and Innovation Incentives Guide – George Municipality
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Research PolicyClinical EvidenceInternational DevelopmentRegulatory FrameworkMunicipal Policy Why This MattersMunicipal-level cannabis research incentives represent a...
CBD Chewing Gum: A Plausible Idea With Very Little Clinical Proof
Despite promising reports, research gaps remain, particularly in understanding the absorption mechanisms, dosing precision, and long-term safety of cannabinoid-based chewing gum.
LOOK: Supporters of former President Rodrigo Duterte pose for a picture with a mascot … – Facebook
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Media LiteracyClinical EvidenceInformation Quality Why This MattersThis appears to be a social media post...
This new therapy turns off pain without opioids or addiction – ScienceDaily
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Pain ManagementResearch MethodologyClinical Evidence Why This MattersWithout access to the actual study details, I...
New Reasons to Think Twice About Cannabis – Psychology Today
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic SafetyClinical EvidencePatient CounselingMedia LiteracyRisk Assessment Why This MattersWithout access to the specific study or...
Can Cannabis Replace Opioids for Chronic Pain? A New Review Maps What We Know—and What Remains Uncertain
Clinical evidence has shown that cannabinoids can significantly reduce the intensity of chronic pain, particularly in cases of neuropathy, multiple sclerosis, arthritis, and other painful conditions that are unresponsive to conventional treatments. However, the full integration of medical cannabis into clinical practice faces significant obstacles, including the need for standardized dosing, long-term safety data, and regulatory frameworks.
Mapping the Landscape: What We Know (and Don’t Know) About Reducing Cannabis Harms
No attempt is made to evaluate their effectiveness, which is not possible given the current state of research, and would require a different kind of research.
CBD’s Promise Outpaces Its Proof: A Comprehensive Review Finds Most Cannabis Products Lack Regulatory-Grade Evidence
The global appeal of therapeutic uses of CBD is growing more rapidly than the scientific evidence supporting its safety and effectiveness.
Cannabinoid Chewing Gum: Promising Concept, Weak Evidence
There has only been one published placebo-controlled trial investigating cannabinoid chewing gum as a drug delivery system… both CBD and placebo reduced pain slightly, but there was no significant difference between CBD and placebo on primary outcomes (mean difference in 30-min pain reduction: 0.1 on VAS, 95% CI: [–0.3, 0.5], p = 0.61).